FDA approves Amgen’s biosimilar to J&J’s rheumatoid arthritis drug

The biosimilar, Avsola, has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune disorders.

Original source: https://health.economictimes.indiatimes.com/news/pharma/fda-approves-amgens-biosimilar-to-jjs-rheumatoid-arthritis-drug/72409782?utm_source=RSS&utm_medium=ETRSS